Kestra Private Wealth Services, LLC Crispr Therapeutics Ag Transaction History
Kestra Private Wealth Services, LLC
- $5.67 Billion
- Q4 2024
A detailed history of Kestra Private Wealth Services, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 20,636 shares of CRSP stock, worth $845,456. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,636
Previous 20,326
1.53%
Holding current value
$845,456
Previous $955,000
14.97%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$368 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$358 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$156 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$114 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$112 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.2B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....